Timothy F. Murphy, MD, senior associate dean for clinical and translational research and SUNY Distinguished Professor of medicine, is leading a major initiative addressing health disparities among people living on Buffalo’s East Side.
Results of a study by lead author Kelseanna Hollis-Hansen, PhD, a former graduate research assistant in the Department of Pediatrics, point to the need for expanding mobile and farmers markets to improve the diets of people who live in low-income communities.
Raymond P. Dannenhoffer, PhD, associate dean for support services, has received the 2019 Newman Award from UB Catholic, the university’s Catholic Campus Ministry.
A UB spinoff company that is developing a low-cost blood test to screen high-risk patients for unruptured brain aneurysms has received $750,000 Phase II Small Business Innovation Research (SBIR) funding from the National Science Foundation (NSF).
UB HEALS, a street medicine outreach initiative of the Jacobs School of Medicine and Biomedical Sciences, held a foot clinic Dec. 5 for Buffalo’s homeless population.
Jerrold C. Winter, PhD, professor of pharmacology and toxicology, is the author of an entertaining and informative new book, “Our Love Affair with Drugs: The History, the Science, the Politics,” published by Oxford University Press.
Otolaryngology surgeons and residents, facial plastic surgeons and other health care personnel got to experience cutting edge technology and techniques during Rhinofest 2019, which took place this fall at the Jacobs School of Medicine and Biomedical Sciences building.
The New York State Area Health Education Center System (AHEC), based in the Department of Family Medicine, has received two federal grants for programs aimed at addressing the opioid epidemic.
Garwood Medical Devices, LLC, has been granted “Breakthrough Device” designation from the U.S. Food and Drug Administration (FDA) for the company’s BioPrax device, a tool it is developing to help eliminate biofilm infections on prosthetic knee implants.
Tracey A. Ignatowski, PhD, assistant professor of pathology and anatomical sciences, has developed a treatment for chronic pain that could have an impact in dealing with the opioid crisis.
University at Buffalo researchers have launched a study that combines artificial intelligence (AI) with data gathered by continuous glucose monitoring devices.
David Dietz, PhD, associate professor and chair of pharmacology and toxicology, is senior author on a pair of papers dealing with the study of drug relapse.
The nation’s first Opioid Intervention Court (OIC) was established in Buffalo in 2017 after — in a single week — three traditional drug-treatment court defendants fatally overdosed on opioids before their second court appearance.
According to Sanjay Sethi, MD, professor of medicine, the recent emergence of severe and even fatal vaping-related lung disease presents a challenge for health care providers and is causing some changes in their practices.
The difficulty of reversing obesity in adults is well known and the deleterious effects that obesity has on an individual’s health can range from diabetes to heart disease to cancer.
Bruce R. Troen, MD, professor of medicine and chief of the Division of Geriatrics and Palliative Medicine, received a rare, perfect score from the National Institutes of Health (NIH) on his grant application for expansion of a center designed to enhance care for older adults throughout Western New York.
Pinaki Sarder, PhD, assistant professor of pathology and anatomical sciences, and doctoral student Brandon Ginley have developed a new method that automates the classification of progressive diabetic kidney disease, reducing variability and boosting precision.
